Location: New York, NY
CIK: 0001825034 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $389M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 246,250 | $109M | 28.1% | $443.28 | — | TR UNIT | 78462F103 |
| INDA | ISHARES TR | 2,425,144 | $106M | 27.2% | $42.12 | — | MSCI INDIA ETF | 46429B598 |
| GLD | SPDR GOLD TR | 555,000 | $98.94M | 25.4% | $178.27 | — | GOLD SHS | 78463V107 |
| — | 23ANDME HOLDING CO | 10,243,122 | $17.93M | 4.6% | $3.83 | — | CLASS A COM | 90138Q108 |
| PMVP | PMV PHARMACEUTICALS INC | 2,545,242 | $15.93M | 4.1% | $36.45 | -85.6% | COM | 69353Y103 |
| FHTX | FOGHORN THERAPEUTICS INC | 1,573,761 | $11.08M | 2.8% | $16.74 | -58.2% | COM | 344174107 |
| — | RAPT THERAPEUTICS INC | 571,233 | $10.68M | 2.7% | $19.50 | — | COM | 75382E109 |
| ALEC | ALECTOR INC | 980,894 | $5.895M | 1.5% | $12.43 | -43.8% | COM | 014442107 |
| ORIC | ORIC PHARMACEUTICALS INC | 747,550 | $5.801M | 1.5% | $28.69 | -80.2% | COM | 68622P109 |
| TNYA | TENAYA THERAPEUTICS INC | 915,705 | $5.375M | 1.4% | $21.49 | -73.0% | COM | 87990A106 |
| — | NGM BIOPHARMACEUTICALS INC | 746,674 | $1.934M | 0.5% | $30.30 | — | COM | 62921N105 |
| — | SURROZEN INC | 802,963 | $442K | 0.1% | $7.08 | — | COM | 86889P109 |